Base-Case Model Results: Average Per-Patient Lifetime Health and Cost Outcomes by Patient Subgroup.
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://figshare.com/articles/dataset/_Base_Case_Model_Results_Average_Per_Patient_Lifetime_Health_and_Cost_Outcomes_by_Patient_Subgroup_/953450
下载链接
链接失效反馈官方服务：
资源简介：
DCC indicates decompensated cirrhosis; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; ICER, incremental cost-effectiveness ratio; PR, peginterferon alfa-2a plus ribavirin; QALY, quality-adjusted life-year; TVR, telaprevir.
aModeled cases of cirrhosis that developed following treatment.
bDue to rounding, ICERs differ slightly from calculations using costs, life-years, and QALYs shown in this table.
cOne treatment dominates another if it exhibits more QALYs at a lower total cost.
创建时间：
2014-03-06
